X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (233898) 233898
Book Review (30829) 30829
Publication (12182) 12182
Newsletter (9422) 9422
Newspaper Article (6857) 6857
Book Chapter (964) 964
Government Document (946) 946
Book / eBook (679) 679
Magazine Article (635) 635
Conference Proceeding (561) 561
Trade Publication Article (381) 381
Web Resource (201) 201
Dissertation (186) 186
Transcript (84) 84
Data Set (25) 25
Report (24) 24
Reference (20) 20
Paper (10) 10
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (205093) 205093
humans (131742) 131742
male (108885) 108885
animals (101624) 101624
female (78863) 78863
rats (50905) 50905
middle aged (47702) 47702
kidney - drug effects (42842) 42842
adult (42109) 42109
urology & nephrology (33235) 33235
kidneys (32520) 32520
aged (31504) 31504
kidney - metabolism (26500) 26500
kidney diseases (25587) 25587
kidney (24459) 24459
transplantation (23156) 23156
mice (22484) 22484
pharmacology & pharmacy (19872) 19872
risk factors (19797) 19797
kidney transplantation (19006) 19006
research (18746) 18746
abridged index medicus (17855) 17855
time factors (17564) 17564
kidney - pathology (16207) 16207
surgery (15297) 15297
treatment outcome (15093) 15093
hypertension (15087) 15087
analysis (14381) 14381
dose-response relationship, drug (13693) 13693
nephrology (13535) 13535
care and treatment (13359) 13359
health aspects (12506) 12506
immunology (12166) 12166
physiology (12089) 12089
adolescent (11784) 11784
mortality (11669) 11669
rats, sprague-dawley (11356) 11356
diabetes (11307) 11307
chronic kidney failure (11234) 11234
blood pressure - drug effects (11115) 11115
medical research (10919) 10919
oxidative stress (10775) 10775
retrospective studies (10598) 10598
expression (10395) 10395
biochemistry & molecular biology (10327) 10327
dogs (10233) 10233
cell line (10055) 10055
rats, wistar (9959) 9959
cancer (9919) 9919
disease (9881) 9881
glomerular filtration rate (9867) 9867
oncology (9768) 9768
creatinine - blood (9699) 9699
liver - drug effects (9581) 9581
rodents (9506) 9506
toxicology (9468) 9468
kidney - physiopathology (9428) 9428
liver (9198) 9198
chronic kidney-disease (9025) 9025
medicine & public health (9005) 9005
child (8987) 8987
kidney failure, chronic - therapy (8817) 8817
blood pressure (8809) 8809
medicine (8668) 8668
proteins (8613) 8613
hemodialysis (8460) 8460
patients (8444) 8444
cells, cultured (8352) 8352
medicine, general & internal (8276) 8276
drugs (8274) 8274
physiological aspects (8060) 8060
therapy (7989) 7989
kidney diseases - chemically induced (7938) 7938
kidney function tests (7899) 7899
immunosuppressive agents - therapeutic use (7861) 7861
medicine, experimental (7857) 7857
chronic kidney disease (7800) 7800
renal dialysis (7791) 7791
disease models, animal (7738) 7738
kidney - physiology (7695) 7695
liver - metabolism (7674) 7674
aged, 80 and over (7627) 7627
follow-up studies (7626) 7626
cells (7615) 7615
cell biology (7569) 7569
drug therapy (7527) 7527
prospective studies (7463) 7463
inflammation (7432) 7432
apoptosis (7265) 7265
kidney failure, chronic - complications (7156) 7156
rats, inbred strains (7035) 7035
studies (6997) 6997
kinetics (6961) 6961
research article (6867) 6867
medicine, research & experimental (6836) 6836
metabolism (6822) 6822
rabbits (6811) 6811
toxicity (6795) 6795
kidney - blood supply (6670) 6670
prognosis (6656) 6656
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (493) 493
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Closed Orders (14) 14
St. Michael's Hospital - Stacks (11) 11
Scarborough Hospital - General (10) 10
UTL at Downsview - May be requested (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Humber River Regional Hospital - Church Stacks (7) 7
Credit Valley Hospital - Stacks (5) 5
Scarborough Hospital - Birchmount (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Toronto East General Hospital - Stacks (5) 5
UofT at Mississauga - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
Holland Bloorview Kids Rehabilitation - Stacks (4) 4
Humber River Regional Hospital - Finch Stacks (4) 4
Lakeridge Health Sciences - Oshawa (4) 4
Credit Valley Hospital - Reference (3) 3
St. Augustine's Seminary - Stacks (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
Markham Stouffville Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Searching (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Media Commons - Microtexts (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Regis College - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Grace (1) 1
Scarborough Hospital - Hospital Department (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Online (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Online (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (238683) 238683
German (3144) 3144
Russian (2345) 2345
French (2269) 2269
Japanese (1878) 1878
Chinese (1342) 1342
Spanish (1023) 1023
Italian (987) 987
Polish (657) 657
Portuguese (181) 181
Czech (164) 164
Hungarian (121) 121
Dutch (116) 116
Ukrainian (115) 115
Danish (109) 109
Bulgarian (100) 100
Swedish (92) 92
Croatian (65) 65
Norwegian (61) 61
Romanian (57) 57
Turkish (55) 55
Korean (51) 51
Slovak (39) 39
Serbian (35) 35
Finnish (34) 34
Hebrew (23) 23
Lithuanian (11) 11
Persian (9) 9
Slovenian (5) 5
Arabic (4) 4
Indonesian (3) 3
Armenian (1) 1
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 7519 - 12
In silico network-based methods have shown promising results in the field of drug development. Yet, most of networks used in the previous research have not... 
SYSTEM | DATABASE | RENIN | GENE | PATHWAY | MULTIDISCIPLINARY SCIENCES | TISSUE | KEGG | NEBIVOLOL | HYPERTENSION | BLOOD-PRESSURE | Hematologic Diseases - pathology | Liver - pathology | Metabolic Diseases - pathology | Respiratory Tract Diseases - metabolism | Kidney - pathology | Skin - metabolism | Hematologic Diseases - metabolism | Humans | Muscle, Skeletal - metabolism | Respiratory Tract Diseases - drug therapy | Respiratory Tract Diseases - genetics | Brain - metabolism | Musculoskeletal Diseases - pathology | Kidney - metabolism | Liver - drug effects | Muscle, Skeletal - drug effects | Myocardium - metabolism | Nervous System Diseases - metabolism | Nutrition Disorders - pathology | Computational Biology - methods | Kidney - drug effects | Liver - metabolism | Nervous System Diseases - drug therapy | Connective Tissue Diseases - metabolism | Neoplasms - drug therapy | Brain - drug effects | Connective Tissue Diseases - drug therapy | Connective Tissue Diseases - pathology | Lung - drug effects | Brain - pathology | Hematologic Diseases - genetics | Prescription Drugs - pharmacokinetics | Digestive System Diseases - pathology | Neoplasms - metabolism | Cardiovascular Diseases - drug therapy | Drugs, Investigational - pharmacokinetics | Respiratory Tract Diseases - pathology | Hematologic Diseases - drug therapy | Metabolic Diseases - drug therapy | Cardiovascular Diseases - pathology | Nervous System Diseases - genetics | Cardiovascular Diseases - genetics | Musculoskeletal Diseases - genetics | Neoplasms - genetics | Lung - metabolism | Skin - pathology | Nervous System Diseases - pathology | Lung - pathology | Musculoskeletal Diseases - drug therapy | Cardiovascular Diseases - metabolism | Musculoskeletal Diseases - metabolism | Nutrition Disorders - drug therapy | Nutrition Disorders - genetics | Myocardium - pathology | Organ Specificity | Digestive System Diseases - genetics | Algorithms | Digestive System Diseases - drug therapy | Nutrition Disorders - metabolism | Metabolic Diseases - metabolism | Digestive System Diseases - metabolism | Metabolic Diseases - genetics | Connective Tissue Diseases - genetics | Muscle, Skeletal - pathology | Neoplasms - pathology | Skin - drug effects | Drug development | Index Medicus
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 10/2017, Volume 12, Issue 10, pp. 1595 - 1600
Background and objectives: RRT and doubling of serum creatinine are considered the objective hard end points in nephrology intervention trials. Because both... 
Creatinine | Nephrology | Diabetes mellitus, type 2 | Humans | Diabetic nephropathies | Tetrazoles | Linear models | Kidney | Glomerular filtration rate | Irbesartan | Losartan | Renal dialysis | Renal replacement therapy | Angiotensin II | Biphenyl compounds | SERUM CREATININE | CHOICE | DECISION | GFR | UROLOGY & NEPHROLOGY | START | IRBESARTAN | NEPHROPATHY | PROGRESSION | DECLINE | Up-Regulation | Angiotensin II Type 1 Receptor Blockers - adverse effects | Renal Insufficiency, Chronic - etiology | Diabetic Nephropathies - etiology | Health Status Indicators | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Biphenyl Compounds - adverse effects | Diabetic Nephropathies - drug therapy | Biphenyl Compounds - therapeutic use | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Time Factors | Clinical Decision-Making | Endpoint Determination | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Kidney - drug effects | Risk Factors | Proportional Hazards Models | Linear Models | Treatment Outcome | Biomarkers - blood | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Renal Insufficiency, Chronic - prevention & control | Diabetes Mellitus, Type 2 - physiopathology | Losartan - therapeutic use | Creatinine - blood | Losartan - adverse effects | Tetrazoles - therapeutic use | Clinical Trials as Topic - methods | Tetrazoles - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Health Status | Research Design | Renal Dialysis | Index Medicus | irbesartan | Diabetic Nephropathies | glomerular filtration rate | Renal Replacement Therapy | Biphenyl Compounds | nephrology | kidney | creatinine | Diabetes Mellitus, Type 2 | Original | renal dialysis
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
REGRESSION | TRIAL | INDUCED SARCOIDOSIS | CTLA-4 BLOCKADE | AUTOIMMUNITY | SAFETY | MULTIDISCIPLINARY SCIENCES | MONOCLONAL-ANTIBODY | PATIENT | HYPOPHYSITIS | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | PARTICIPANTS | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Index Medicus | Abridged Index Medicus | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track | Pharmaceutical Sciences | Basic Medicine | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | FARMACI | Farmaceutiska vetenskaper
Journal Article